The role of evolocumab (Repatha ®) in the treatment of patients with cardiovascular disease
By: Katie Lee, PharmD Candidate c/o 2019 - In 2015, FDA approved evolocumab (Repatha ®), a human monoclonal antibody of…
FDA approves tisagenlecleucel (Kymriah ™): first gene therapy available in the United States
By: Anna Diyamandoglu, PharmD Candidate c/o 2020 - The specificity of individuals’ genetic makeup has been one of the primary…
White coat ceremony: a rite of passage
By: Katharine Russo, PharmD Candidate c/o 2021 - A traditional rite of passage, the 18th Annual Pharmacy White Coat Ceremony…
The future of pharmacy at our fingertips
By: Gabrielle Flavoni, PharmD Candidate c/o 2018 - Pharmacists have always been deemed one of the most accessible health care…
Pharmacy Pearls: Current Treatment for Hepatitis C
By: Vicky Liu, PharmD Candidate c/o 2018 - Hepatitis is an inflammation of the liver commonly caused by viruses which…
Ketogenic Diets for Diabetes Mellitus and Obesity
By: Anna Chen, PharmD Candidate c/o 2020 - Every day the public faces an onslaught of a new fad diet…
FDA Approves edaravone (Radicava™) to Treat ALS
By: Thanesha Graham, PharmD Candidate c/o 2019 - Amyotrophic lateral sclerosis (ALS) is commonly referred to as Lou Gehrig’s disease.…
The Prior Authorization Process and its Effect on Patient Care
By: Zachary Reale, PharmD Candidate c/o 2018 - Today there are over fifty oral anticancer agents on the market and…
Valbenazine (Ingrezza®): The First FDA Approved Drug for Tardive Dyskinesia
By: Yan Yi Chan, PharmD Candidate c/o 2018 - Tardive dyskinesia is a movement disorder characterized by involuntary and repetitive…
Pharmacy Lobby Day 2017, A Student’s Perspective
By: Zachary Reale, PharmD Candidate c/o 2018 - Every April, pharmacists and pharmacy students from all across New York State…